Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|June 27, 2002
Rheumatoid arthritis: developing pharmacological therapiesRichard J Misischia, Larry W MorelandPharmacoeconomics|May 26, 2004
Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritisLarry W MorelandThe Journal of Rheumatology. Supplement|July 6, 2007
Disease modifiers: making the right therapeutic choices for our patientsLarry W MorelandArthritis Research & Therapy|April 30, 2003
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of actionLarry W MorelandAnnals of the New York Academy of Sciences|January 16, 2010
Cytokines as targets for anti-inflammatory agentsLarry W MorelandJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Biologic therapies on the horizon for rheumatoid arthritisLarry W MorelandDrug Safety|December 24, 2002
Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritisTed R Mikuls, Larry W MorelandExpert Opinion on Investigational Drugs|July 23, 2004
Rheumatoid arthritis: developing pharmacological therapiesJoel D Abbott, Larry W MorelandExpert Review of Clinical Immunology|October 29, 2010
Certolizumab pegol: a new biologic targeting rheumatoid arthritisAarat M Patel, Larry W MorelandCurrent Rheumatology Reports|March 13, 2014
Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritisYong Gil Hwang, Larry W MorelandPageof 15